Sign in
Taking peopleNo phase

AI risk alerts to help doctors spot iron deficiency in adult clinic patients

Tests an AI risk display for doctors finding iron deficiency in adults.

Key facts

Who runs it
China Medical University Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Assessing Clinical Impact of AI for Iron Deficiency
Status
Recruiting
People taking part
2,196 people, planned
Started
1 Apr 2026
Expected to end
Mar 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • AI Risk Display
Record updated
26 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults seen at outpatient clinics in Internal Medicine, Family Medicine or Hematology/Oncology who have a routine complete blood count (CBC). It tests whether an AI risk alert for doctors helps find iron deficiency.

Age
18 years or older
Sex
All sexes
Biomarker or test result
A routine complete blood count (CBC) done during the clinic visit, with the report available in the hospital lab system.

Main reasons for not taking part

  • Visits with missing or incomplete key identifiers, such as the patient ID number
  • Visits without a valid department code in the hospital system
  • Visits with incomplete or missing lab data needed for the AI system
  • Repeat blood count visits from the same patient; only the first visit counts

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adults aged 18 years or older
  • Patients attending outpatient clinics of participating departments including 2.1. Internal Medicine, 2.2 Family Medicine 2.3. Hematology/Oncology
  • Completion of a routine complete blood count (CBC) as part of usual clinical care during the outpatient encounter
  • Availability of the CBC report in the institutional laboratory information system, allowing sufficient data for analysis

Who cannot take part

  • Encounters with incomplete or missing laboratory data required to activate the AI system
  • Encounters with missing or incomplete key identifiers (e.g., patient identification number, ) that prevent determination of exposure status (AI information displayed vs not displayed) or assessment of outcomes within the defined follow-up period
  • Encounters without a valid department code required by the information system to trigger the randomization mechanism and AI risk display
  • Repeated CBC encounters from the same patient during the study period, if applicable; only the first eligible encounter will be included to avoid duplication

This trial is currently available in Taiwan.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether an AI-based risk notification system integrated into routine clinical care can improve the clinical detection of iron deficiency in adult patients attending Internal Medicine, Family Medicine, and Hematology/Oncology clinics at China Medical University Hospital in Taiwan.

Read full original descriptionShow less

The main questions this study aims to answer are:

1. Does displaying AI-generated iron deficiency risk classification to physicians increase the overall detection rate of iron deficiency at the population level? 2. Does the AI-based risk notification influence physicians' diagnostic behavior by increasing the rate at which ferritin testing is ordered specifically for suspected iron deficiency? 3. Among ferritin tests ordered for suspected iron deficiency, does the diagnostic yield (positivity rate) remain appropriate, reflecting efficient use of testing resources? 4. Are the effects of the AI-assisted intervention consistent among patients with anemia and without anemia?

Comparison Groups Researchers will compare clinical encounters in which physicians receive AI-generated iron deficiency risk information (the Prompt Group) with encounters in which physicians receive standard laboratory results without AI risk display (the Control Group). The comparison focuses on differences in iron deficiency detection, ferritin ordering behavior for suspected iron deficiency, and diagnostic yield.

What Participants Will Experience

1. No Additional Procedures:

As this is a pragmatic study embedded in routine clinical care, participants will not undergo any additional blood draws, invasive procedures, or clinic visits beyond standard care. 2. Routine Care Only:

Patients attend their scheduled outpatient visits and receive complete blood count (CBC) testing as ordered by their treating physician, independent of study participation. 3. Background Data Integration:

The AI system operates within the hospital's information system, analyzing routinely collected CBC data after results become available. No additional data entry or action is required from patients. 4. Physician Autonomy Preserved:

The AI provides a non-mandatory risk classification as decision support. For patients identified as high risk, the system may display an informational prompt suggesting consideration of iron-related testing if no recent testing is found. All diagnostic and management decisions remain entirely at the discretion of the treating physician.

The 2 groups in the trial

  • AI displayTreatment being tested

    Treatment: AI Risk Display

  • ControlNo study treatment, for comparison

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of the Clinical Impact of Machine Learning-Based Risk Classification Using Blood Analysis on Iron Deficiency Detection
Plain-language title
AI risk alerts to help doctors spot iron deficiency in adult clinic patientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
26 May 2026